by mediaid | Dec 8, 2024 | Lung Cancer Treatment
Alecnib 150 mg, also known as Alectinib, is an advanced ALK (anaplastic lymphoma kinase) inhibitor used for the treatment of ALK-positive non-small cell lung cancer (NSCLC). It has been developed as a highly potent and selective therapy aimed at improving the survival...
by mediaid | Dec 8, 2024 | Lung Cancer Treatment
Osimertinib 80 MG is a revolutionary treatment for patients suffering from EGFR-mutation-positive non-small cell lung cancer (NSCLC). This medication represents an important milestone in the treatment of this particular form of cancer, offering a targeted therapy with...
by mediaid | Aug 19, 2024 | Lung Cancer Treatment
Tagrix (Osimertinib) has revolutionized the treatment landscape for Non-Small Cell Lung Cancer (NSCLC), especially in patients harbouring specific genetic mutations. As a third-generation Epidermal Growth Factor Receptor (EGFR) inhibitor, Tagrix targets both the...
by mediaid pharmacy | Nov 10, 2023 | Lung Cancer Treatment
Lung cancer is a challenging disease, affecting millions of people worldwide. Thankfully, medical science has made significant progress in finding treatments that offer hope and relief. One such advancement is the use of a medication called Osicent Osimertinib 80 mg....
by mediaid | Oct 20, 2022 | Lung Cancer Treatment
We all now say that cancer is a chronic disease, not a terminal illness. Why do you say that, and on what basis? Frontier Information of Health Prediction Station: With the research and development of medicine, doctors and experts have proposed: If there are drugs...
by mediaid | May 13, 2022 | Lung Cancer Treatment
Osicent medicine treats lung cancer whether effective or not, uses, and determines the side effects, Mediaid pharmacy will cover everything in this blog article. What drug is Osicent ? Osicent is a cancer drug that interferes with the growth and spread of cancer cells...
